Clinical significance of CYP2C19 polymorphisms on the metabolism and pharmacokinetics of 11β-hydroxysteroid dehydrogenase type-1 inhibitor BMS-823778.
about
Clinical significance of CYP2C19 polymorphisms on the metabolism and pharmacokinetics of 11β-hydroxysteroid dehydrogenase type-1 inhibitor BMS-823778.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Clinical significance of CYP2C ...... e type-1 inhibitor BMS-823778.
@en
Clinical significance of CYP2C ...... e type-1 inhibitor BMS-823778.
@nl
type
label
Clinical significance of CYP2C ...... e type-1 inhibitor BMS-823778.
@en
Clinical significance of CYP2C ...... e type-1 inhibitor BMS-823778.
@nl
prefLabel
Clinical significance of CYP2C ...... e type-1 inhibitor BMS-823778.
@en
Clinical significance of CYP2C ...... e type-1 inhibitor BMS-823778.
@nl
P2093
P2860
P50
P356
P1476
Clinical significance of CYP2C ...... se type-1 inhibitor BMS-823778
@en
P2093
Donglu Zhang
Lifei Wang
Lisa Iacono
Weiqi Chen
William Griffith Humphreys
P2860
P304
P356
10.1111/BCP.13421
P407
P577
2017-10-04T00:00:00Z